Galderma Successfully Issued an Inaugural CHF 500 Million Bond

Contributed by: Business Wire

Logo

Tags

Biotechnology

Pharmaceutical

Health

Other Health

inaugural bond

More Like This

Galderma Announces Intention to Float on the SIX Swiss Exchange

Galderma Prices IPO at CHF 53 Per Share and Will Start Trading on the SIX Swiss Exchange Tomorrow

Galderma Launches IPO on the SIX Swiss Exchange and Sets Price Range

Galderma Announces Full Exercise of Over-Allotment Option

Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth

Galderma Delivers Record Net Sales of 3.259 B USD in the First Nine Months of 2024, Demonstrates Significant Innovation Progress, Confirms and Narrows Its Full Year Net Sales Guidance

Galderma Delivers Record Net Sales of 2.2 Billion USD and 10.8% Year-on-Year Growth at Constant Currency for the First Half of 2024

Galderma Announces Record 2023 Net Sales of Over 4 B USD and Significant Core EBITDA Margin Expansion